These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6401325)
1. A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine. Kung HF; Tramposch KM; Blau M J Nucl Med; 1983 Jan; 24(1):66-72. PubMed ID: 6401325 [TBL] [Abstract][Full Text] [Related]
2. Temporal evolution of brain distribution of IMP and HIPDM. Concise communication. Moretti JL; Kung HF; Cesaro P; Blau M; Defer G; Holman L; Vigneron N; Rapin JR Nucl Med Commun; 1987 Jul; 8(7):597-602. PubMed ID: 3500438 [TBL] [Abstract][Full Text] [Related]
3. Radioactive iodine exchange reaction of HIPDM: kinetics and mechanism. Lui B; Chang J; Sun JS; Billings J; Steves A; Ackerhalt R; Molnar M; Kung HF J Nucl Med; 1987 Mar; 28(3):360-5. PubMed ID: 3819852 [TBL] [Abstract][Full Text] [Related]
4. Regional distribution study of brain perfusion and metabolic agents in normal and tumour bearing rat brains using autoradiographic technique. Murugesan S; Patel MC; Ramanathan P; Samuel AM; Lalitharao VS; Hasgekar N Int J Rad Appl Instrum B; 1991; 18(3):331-7. PubMed ID: 2071446 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of [iodine-125]N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3- propanediamine lung uptake using an isolated-perfused lung model. Slosman DO; Brill AB; Polla BS; Alderson PO J Nucl Med; 1987 Feb; 28(2):203-8. PubMed ID: 3806224 [TBL] [Abstract][Full Text] [Related]
6. A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the human. Holman BL; Lee RG; Hill TC; Lovett RD; Lister-James J J Nucl Med; 1984 Jan; 25(1):25-30. PubMed ID: 6610030 [TBL] [Abstract][Full Text] [Related]
7. No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-[123I] iodobenzyl)-1,3-propanediamine. Moerlein SM; Lannoye GS; Welch MJ Int J Rad Appl Instrum A; 1990; 41(3):253-7. PubMed ID: 2158950 [TBL] [Abstract][Full Text] [Related]
8. Metabolic and kinetic considerations in the use of [125I]HIPDM for quantitative measurement of regional cerebral blood flow. Lucignani G; Nehlig A; Blasberg R; Patlak CS; Anderson L; Fieschi C; Fazio F; Sokoloff L J Cereb Blood Flow Metab; 1985 Mar; 5(1):86-96. PubMed ID: 3871785 [TBL] [Abstract][Full Text] [Related]
9. Preliminary toxicity studies on N,N,N'-trimetyl-N' (2-hydroxyl-3-methyl-5-iodobenzyl)-1,3-propanediamine (HIPDM), a new brain perfusion imaging agent. Kostyniak PJ Drug Chem Toxicol; 1984; 7(5):451-62. PubMed ID: 6334599 [TBL] [Abstract][Full Text] [Related]
14. Accumulation and metabolism of [125I]HIPDM in the rat pancreas. Saji H; Kuge Y; Tsutsumi D; Yamamoto K; Konishi J; Yokoyama A Ann Nucl Med; 1991 Nov; 5(4):157-61. PubMed ID: 1797071 [TBL] [Abstract][Full Text] [Related]
15. Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine. de Bruine JF; van Royen EA; Vyth A; de Jong JM; van der Schoot JB J Nucl Med; 1985 Aug; 26(8):925-30. PubMed ID: 2993550 [TBL] [Abstract][Full Text] [Related]